$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
多吉美和舒尼替尼肾癌患者如何选择?
2025-10-19 11:44:20
Check Details
乐伐替尼和依维莫司治疗转移性肾细胞癌
2025-10-19 11:44:20
Check Details
舒尼替尼治疗转移性肾细胞癌
2025-10-19 11:44:20
Check Details
FDA批准舒尼替尼治疗晚期肾细胞癌
2025-10-19 11:44:20
Check Details
卡博替尼治疗肾癌优于舒尼替尼
2025-10-19 11:44:20
Check Details
肾癌治疗用药乐伐替尼+依维莫司
2025-10-19 11:44:20
Check Details
依维莫司+乐伐替尼治疗晚期肾癌
2025-10-19 11:44:20
Check Details
舒尼替尼治疗转移性肾细胞癌患者
2025-10-19 11:44:20
Check Details
舒尼替尼治疗肾癌有较高的疗效
2025-10-19 11:44:20
Check Details
舒尼替尼一线治疗转移性肾细胞癌
2025-10-19 11:44:20
Check Details
舒尼替尼获批治疗转移性肾癌
2025-10-19 11:44:20
Check Details
索拉非尼在晚期难治性实体瘤患者中安全性:I期试验
2025-10-19 11:44:20
Check Details
1
2
...
2091
2092
2093
2094
2095
2096
2097
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
2
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
3
Adagrasib Medication Management Guide for Special Populations
4
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
5
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
6
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
7
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
8
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
9
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
10
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
11
Complete Guide to Dosage and Dose Adjustment of Entrectinib
12
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer